Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: A Study of Tanezumab in Adults With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tanezumab in adults with chronic low back pain completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Low Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-07-07